Literature DB >> 19423487

[Malnutrition in cancer patient: when to have a specialized consultation?].

S Antoun1, V Baracos.   

Abstract

Nutritional management of the cancer patient cannot be ignored, given the well-established links between malnutrition and mortality, postoperative complications, toxicity of radiation and chemotherapy, and quality of life. The expertise of a medical specialist in nutrition is often required given the diversity of the clinical presentation of malnutrition in cancer patients and in certain areas lacking evidence in the literature. In at least some situations, such as for malnourished patients requiring surgery, preoperative nutrition (normally enteral nutrition if possible), is indicated and is also the subject of international recommendations/clinical practice guidelines. The role of the specialist in nutrition is to disseminate such information. There are some situations where the literature offers useful approaches, even if there are no guidelines/recommendations. For example, in disease for which there are not curative therapies but the patient is not yet in a terminal stage, it is legitimate to propose parenteral nutrition in the case of partial bowel obstruction, without waiting for advice from a nutrition specialist. By contrast, his advice is of interest in the ethical discussion which sometimes surrounds decisions to initiate artificial nutrition in patients in the terminal phase. Nutritional recommendations are difficult to formulate for patients with solid tumors on chemotherapy, because there are few data in the literature. The expertise of the specialist in nutrition in this case is most effectively deployed when active treatment of the disease is planned (earlier rather than later in the disease trajectory, in patients responding to treatment for whom further treatment is planned, participants in phase I studies). For cancers of the head and neck preoperative enteral nutrition is recommended for malnourished patients. The literature also provides some practical solutions, even in the absence of well-defined recommendations in some instances. Enteral nutrition is also indicated, without consulting a specialist in nutrition, during radiotherapy when intake falls, to prevent the development of malnutrition. Given the high frequency and important consequences of malnutrition in patients receiving combined radiation and chemotherapy, it is appropriate to initiate enteral nutrition at the 3rd week of treatment. The role of the specialist in nutrition is to interpret the literature and to develop procedures for specific cases.

Entities:  

Mesh:

Year:  2009        PMID: 19423487     DOI: 10.1684/bdc.2009.0860

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  5 in total

1.  Poor dental condition is a factor of imbalance of the nutritional status at the outset of management of head and neck cancer.

Authors:  Laurent Devoize; Camille Dumas; Céline Lambert; Mohamed El Yagoubi; Thierry Mom; Nicolas Farigon; Laurent Gilain; Yves Boirie; Nicolas Saroul
Journal:  Clin Oral Investig       Date:  2021-08-20       Impact factor: 3.606

2.  Analysis of Current Status on a New Public Health Nutrition Service Pattern in China: A Nutrition Outpatient Clinic-Based Study.

Authors:  Yunpeng Jin; Xiaolin Li
Journal:  Biomed Res Int       Date:  2018-08-09       Impact factor: 3.411

Review 3.  Nutritional Therapy in Cancer Patients Receiving Chemoradiotherapy: Should We Need Stronger Recommendations to Act for Improving Outcomes?

Authors:  Paolo Cotogni; Paolo Pedrazzoli; Elisabeth De Waele; Giuseppe Aprile; Gabriella Farina; Silvia Stragliotto; Francesco De Lorenzo; Riccardo Caccialanza
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

4.  Assessment of nutritional status of gynecological cancer cases in India and comparison of subjective and objective nutrition assessment parameters.

Authors:  Ushashree Das; Shilpa Patel; Kalpana Dave; Ronak Bhansali
Journal:  South Asian J Cancer       Date:  2014-01

5.  Sarcopenic Factors May Have No Impact on Outcomes in Ovarian Cancer Patients.

Authors:  Naomi Nakayama; Kentaro Nakayama; Kohei Nakamura; Sultana Razia; Satoru Kyo
Journal:  Diagnostics (Basel)       Date:  2019-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.